General Information of This Metabolic Reaction (MR) (ID: MR001615)
Formula
SVG example
N-Oxidation
Reactant Medifoxamine Product N-oxide medifoxamine
Reactant Info Product Info
Metabolic Type Oxidation - N-Oxidation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001616 Medifoxamine Acidic medifoxamine Unclear Medifoxamine [1]
MR001617 Medifoxamine Hydroxymedifoxamine Oxidation - Hydroxylation Medifoxamine [2]
MR001614 Medifoxamine N-desmethylmedifoxamine Oxidation - N-Demethylation Medifoxamine [3]
References
1 Solid-phase extraction of diltiazem and its metabolites from plasma prior to high-performance liquid chromatography J Chromatogr. 1990 Jun 29;528(2):542-6. doi: 10.1016/s0378-4347(00)82416-0.
2 Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest. 1990 Aug;86(2):385-91. doi: 10.1172/JCI114723.
3 Measurement of medifoxamine metabolites in urine by high-performance liquid chromatography J Chromatogr. 1990 Jun 29;528(2):531-6. doi: 10.1016/s0378-4347(00)82414-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.